ArticleFrontiers in immunology2023

A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice.

Alexandre Quilbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.